MSB 5.24% $1.11 mesoblast limited

Yes , my blurry eyed morning self meant to say. Potency assay...

  1. 2,687 Posts.
    lightbulb Created with Sketch. 1733
    Yes , my blurry eyed morning self meant to say.

    Potency assay approval will lead to manufacturing at scale.

    That manufacturing at scale creates a valuation.

    That valuation may be used in calculations of a takeover offer.

    I expect Novartis will swallow Rem-L whole, if not all of Mesoblast.

    Reg
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.11
Change
0.055(5.24%)
Mkt cap ! $1.261B
Open High Low Value Volume
$1.05 $1.13 $1.04 $6.781M 6.207M

Buyers (Bids)

No. Vol. Price($)
3 43856 $1.11
 

Sellers (Offers)

Price($) Vol. No.
$1.11 66000 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.